| 1 |
Atomically Thin MoS 2 : A New Direct-Gap Semiconductor
Kin Fai Mak, Changgu Lee, James Hone et al. · Physical Review Letters
Open access |
24 Sep 2010 |
15,416 |
| 2 |
Large-scale pattern growth of graphene films for stretchable transparent electrodes
Keun‐Soo Kim, Yüe Zhao, Houk Jang et al. · Nature
|
14 Jan 2009 |
10,482 |
| 3 |
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al. · Nature
Open access |
Aug 2016 |
10,439 |
| 4 |
Roll-to-roll production of 30-inch graphene films for transparent electrodes
Sukang Bae, Hyeongkeun Kim, Youngbin Lee et al. · Nature Nanotechnology
Open access |
20 Jun 2010 |
8,140 |
| 5 |
Lead Iodide Perovskite Sensitized All-Solid-State Submicron Thin Film Mesoscopic Solar Cell with Efficiency Exceeding 9%
Hui‐Seon Kim, Chang-Ryul Lee, Jeong‐Hyeok Im et al. · Scientific Reports
Open access |
21 Aug 2012 |
8,073 |
| 6 |
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al. · New England Journal of Medicine
Open access |
13 May 2020 |
7,547 |
| 7 |
Boron nitride substrates for high-quality graphene electronics
Cory R. Dean, Andrea F. Young, Inanc Meric et al. · Nature Nanotechnology
Open access |
22 Aug 2010 |
7,159 |
| 8 |
Solvent engineering for high-performance inorganic–organic hybrid perovskite solar cells
Nam Joong Jeon, Jun Hong Noh, Young Chan Kim et al. · Nature Materials
|
4 Jul 2014 |
6,715 |
| 9 |
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst, Paul Baas, Dong‐Wan Kim et al. · The Lancet
|
19 Dec 2015 |
6,590 |
| 10 |
Compositional engineering of perovskite materials for high-performance solar cells
Nam Joong Jeon, Jun Hong Noh, Woon Seok Yang et al. · Nature
|
2015 |
6,449 |
| 11 |
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon et al. · New England Journal of Medicine
Open access |
19 Apr 2015 |
6,312 |
| 12 |
High-performance photovoltaic perovskite layers fabricated through intramolecular exchange
Woon Seok Yang, Jun Hong Noh, Nam Joong Jeon et al. · Science
|
21 May 2015 |
6,248 |
| 13 |
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
Mayank Goyal et al. · New England Journal of Medicine
Open access |
11 Feb 2015 |
6,122 |
| 14 |
The CMS experiment at the CERN LHC
S. Chatrchyan et al. · Journal of Instrumentation
Open access2,047 authors |
14 Aug 2008 |
5,508 |
| 15 |
Chemical Management for Colorful, Efficient, and Stable Inorganic–Organic Hybrid Nanostructured Solar Cells
Jun Hong Noh, Sang Hyuk Im, Jin Hyuck Heo et al. · Nano Letters
|
21 Mar 2013 |
4,835 |
| 16 |
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al. · The Lancet
Open access |
12 Dec 2016 |
4,817 |
| 17 |
Ultra-large-scale syntheses of monodisperse nanocrystals
Jongnam Park, Kwangjin An, Yosun Hwang et al. · Nature Materials
|
28 Nov 2004 |
4,072 |
| 18 |
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
Christophe Ginestier, Min Hee Hur, Emmanuelle Charafe‐Jauffret et al. · Cell stem cell
Open access |
Nov 2007 |
4,039 |
| 19 |
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al. · Nature
Open access1,384 authors |
5 Feb 2020 |
3,854 |
| 20 |
Real-space observation of a two-dimensional skyrmion crystal
Xiuzhen Yu, Y. Onose, Naoya Kanazawa et al. · Nature
|
Jun 2010 |
3,507 |
| 21 |
Next Generation 5G Wireless Networks: A Comprehensive Survey
Mamta Agiwal, Abhishek Kumar Roy, Navrati Saxena · IEEE Communications Surveys & Tutorials
|
2016 |
3,501 |
| 22 |
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
Alice Tsang Shaw et al. · New England Journal of Medicine
Open access |
Jun 2013 |
3,429 |
| 23 |
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
Tony S.K. Mok, Yi-Long Lung Cancer Wu, Myung‐Ju Ahn et al. · New England Journal of Medicine
Open access |
6 Dec 2016 |
3,396 |
| 24 |
Pan-cancer analysis of whole genomes
Lauri A. Aaltonen et al. · Nature
Open access1,324 authors |
5 Feb 2020 |
3,360 |
| 25 |
Differences Between Tight and Loose Cultures: A 33-Nation Study
Michele Joy Gelfand et al. · Science
Open access |
26 May 2011 |
3,323 |
| 26 |
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid et al. · New England Journal of Medicine
Open access |
26 Feb 2020 |
3,298 |
| 27 |
6.5% efficient perovskite quantum-dot-sensitized solar cell
Jeong‐Hyeok Im, Chang-Ryul Lee, Jin‐Wook Lee et al. · Nanoscale
|
2011 |
3,167 |
| 28 |
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
David H Adams et al. · New England Journal of Medicine
Open access |
4 Jul 2018 |
3,046 |
| 29 |
Efficient perovskite solar cells via improved carrier management
Jason J. Yoo, Gabkyung Seo, Matthew R. Chua et al. · Nature
|
24 Feb 2021 |
2,964 |
| 30 |
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Kathleen N. Moore et al. · New England Journal of Medicine
Open access |
21 Oct 2018 |
2,927 |
| 31 |
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
Courtney Denton Dinardo et al. · New England Journal of Medicine
Open access |
12 Aug 2020 |
2,918 |
| 32 |
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Matthew David Hellmann et al. · New England Journal of Medicine
Open access |
28 Sep 2019 |
2,901 |
| 33 |
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Vassily Vladimirovich Trubetskoy et al. · Nature
Open access613 authors |
8 Apr 2022 |
2,894 |
| 34 |
Tightly bound trions in monolayer MoS2
Kin Fai Mak, Keliang He, Changgu Lee et al. · Nature Materials
Open access |
30 Nov 2012 |
2,886 |
| 35 |
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Louis Fehrenbacher, Alexander I. Spira, Marcus D. Ballinger et al. · The Lancet
|
9 Mar 2016 |
2,823 |
| 36 |
High-Efficiency Perovskite Solar Cells
Jin Young Kim, Jin‐Wook Lee, Hyun Suk Jung et al. · Chemical Reviews
Review |
28 Jul 2020 |
2,810 |
| 37 |
Recent development of two-dimensional transition metal dichalcogenides and their applications
Wonbong Choi, Nitin P. Choudhary, Gang Han et al. · Materials Today
Open access |
9 Jan 2017 |
2,786 |
| 38 |
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Shanu Modi et al. · New England Journal of Medicine
Open access |
5 Jun 2022 |
2,702 |
| 39 |
Temporal networks
Petter Holme, Jari Saramäki · Physics Reports
Open access |
6 Mar 2012 |
2,699 |
| 40 |
Wireless Networks With RF Energy Harvesting: A Contemporary Survey
Xiao Lu, Ping Wang, Dusit Tao Niyato et al. · IEEE Communications Surveys & Tutorials
|
10 Nov 2014 |
2,683 |
| 41 |
Efficient inorganic–organic hybrid heterojunction solar cells containing perovskite compound and polymeric hole conductors
Jin Hyuck Heo, Sang Hyuk Im, Jun Hong Noh et al. · Nature Photonics
Open access |
3 May 2013 |
2,674 |
| 42 |
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
José Baselga, Javier Cortés, Sung‐Bae Kim et al. · New England Journal of Medicine
Open access |
7 Dec 2011 |
2,559 |
| 43 |
Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer
Solange Peters, D. Ross Camidge, Alice Tsang Shaw et al. · New England Journal of Medicine
Open access |
6 Jun 2017 |
2,523 |
| 44 |
Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017
Heber MacMahon, David P. Naidich, Jin Mo Goo et al. · Radiology
|
Mar 2017 |
2,516 |
| 45 |
Water photolysis at 12.3% efficiency via perovskite photovoltaics and Earth-abundant catalysts
Jingshan Luo, Jeong‐Hyeok Im, Matthew T. Mayer et al. · Science
Open access |
25 Sep 2014 |
2,509 |
| 46 |
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im et al. · The Lancet Oncology
|
10 Dec 2011 |
2,403 |
| 47 |
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Yoon‐Koo Kang et al. · The Lancet
Open access |
12 Oct 2017 |
2,317 |
| 48 |
Highly Reproducible Perovskite Solar Cells with Average Efficiency of 18.3% and Best Efficiency of 19.7% Fabricated via Lewis Base Adduct of Lead(II) Iodide
Namyoung Ahn, Dae‐Yong Son, In-Hyuk Jang et al. · Journal of the American Chemical Society
|
30 Jun 2015 |
2,311 |
| 49 |
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Luis G Paz-Ares et al. · The Lancet
246 authors |
4 Oct 2019 |
2,310 |
| 50 |
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Răzvan Cristescu et al. · Nature Medicine
|
20 Apr 2015 |
2,299 |